Canadian investment company Brookfield to acquire Indian Emami Power
By Akshay Kedari  Date: 2020-06-08

Canadian investment company Brookfield to acquire Indian Emami Power

Brookfield Asset Management, a renowned Canadian investment company, has signed an agreement to purchase Emami Power, Emami Group’s solar power business. Emami Group, a renowned Indian diversified conglomerate based in Kolkata, has reportedly confirmed this acquisition.

Director of Emami Group, Harsha V Agarwal stated that as a part of the company’s divestment plan regarding business assets that are not at its core, Emami is thrilled to have closed this deal with Brookfield to sell its solar power business to the Canadian renewable energy industry player. 

According to reports, Emami Power is not directly connected to the main company, Emami Ltd., but is a unit that falls under the promoter group.

As per reliable sources, the company is looking to rapidly reduce its debt load on a group level to be debt free and also redeem promoter pledge within its flagship FMCG arm. This agreement is a part of the company’s current non-core asset monetization initiative. Agarwal and Goenka families still continue to possess a majority stake in several Emami group firms.  

is confident in the solar power business and is currently looking to develop a platform or a portfolio of solar and other alternate energy assets throughout India. The solar assets Brookfield has procured from Emami are already operational as well as functional.

As per the company officials, law firm Khaitan and Co was involved in the deal as a legal advisor to Emami Group, while Yes Securities worked as the company’s financial advisor for the transaction.

According to Emami Power’s official website, the firm had already established 10 MWp (megawatt peak) solar power projects in Gujarat, a 22.5 MWp solar power project in Uttarakhand, a 3.3 MWp solar power project in Tamil Nadu, and a 11 MWp solar power projects in Karnataka

Financial terms regarding the acquisition of the solar assets have yet to be disclosed by either of the companies.

Source credit:  https://www.moneycontrol.com/news/business/companies/exclusive-brookfield-buys-emami-groups-solar-business-deal-part-of-conglomerates-non-core-asset-sale-strategy-5369151.html

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...